Virbac stock rebounds 3%, leading SBF 120 with RSI at 25
The rebound is clear this Friday morning for the veterinary laboratory based in Carros: the stock posts the best performance in its index, in a session where the SBF 120 advances modestly. This uptick comes after several weeks of selling pressure that brought the price to levels close to a short-term support level.
Virbac leading SBF 120 despite RSI in extreme oversold territory at 25
In trading this Friday, Virbac gains 3.15% to €311.50, posting the strongest advance in the SBF 120. The stock is recovering from the previous day, which had served as a floor for the price, with the €302 support holding firm. This rebound is nevertheless occurring in a context that remains technically fragile: the RSI at 25 indicates an extreme oversold configuration, consistent with the depreciation of nearly 3% accumulated over the week, but the price remains below the 20-day moving average at €323.93 (gap of -3.84%) and the 50-day moving average at €329.51 (gap of -5.47%).
These two moving averages act as nearby resistance levels, and the 200-day moving average at €348.21 is still 10.54% above the current price. Today's rebound, however visible in the index ranking, is insufficient to reverse the bearish configuration established over several weeks, with a one-month performance of -6.74%.
Half-year results expected on September 17, amid rising interest rates in the eurozone
The next concrete milestone for the stock, which had broken its €314 support last Wednesday, is the publication of 2026 half-year results, scheduled for September 17. An SFAF meeting dedicated to the financial and strategic information for the first half is planned for September 18. These two milestones arrive in a heavy macroeconomic environment: the ECB raised its key interest rate to 2.50% yesterday, its second increase of the year, amid inflation that continues to exceed the target, driven by energy prices.
For a group like Virbac, whose animal health activities span multiple continents, the rise in financing costs in the eurozone and pressure on margins linked to energy represent a key parameter to monitor. The half-year publication on September 17 will provide the first quantified elements to assess the operational resilience of the group in this context.
